rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Oxygenta Pharmaceutical Ltd - Board Meeting Outcome for Submission Of Un-Audited Financial Results For The Quarter Ended 30Th June, 2022 Ref: Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Download announcement < Back
12 Aug 2022
The Board at its meeting held today, i.e. Friday, 12th August, 2022, transacted inter-alia, the following businesses: 1. Financial Results: The Board approved the Un-audited Financial Results for the first quarter ended 30th June, 2022. In this regard please find the enclosed: ? Un-audited Financial Results of the Company for the quarter ended 30th June, 2022 ? Limited Review Report in respect of the Un-audited Financial Results of the Company for the first quarter ended 30th June, 2022 2. Other Corporate matters This is for your information and records.
View all announcements for Oxygenta Pharmaceutical Ltd Source: BSE India

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips